IP Library Granted Patent US 7,262,179
Granted Patent B2
US 7,262,179 · App. 10/447,062 · Granted Aug 28, 2007

Wound care compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,262,179
App. No.
10/447,062
Granted
Aug 28, 2007
Kind
B2
Abstract

Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The composition may be in sprayable form or dispersed in an aqueous solution. Methods of making and using the compositions are also described.

Claims (7)

1. A composition for the treatment of a wound or skin injury, which is in sprayable form prior to application to the wound or skin injury, comprising from 0.25% to 1.5% by weight of the composition of a gellan gum, the composition further comprising an active ingredient dissolved or dispersed in the composition, wherein the active ingredient is selected from the group consisting of hyaluronic acid, esterified hyaluronic acid, an antiseptic, an antifungal agent, an antibacterial agent, and mixtures thereof, the viscosity of said composition increasing such that once applied to a wound or skin injury an immobile gel is formed.

2. The composition of claim 1 wherein the active ingredient is dissolved or dispersed in an aqueous solution of gellan gum.

3. The composition of claim 1 , wherein the active ingredient is present in an amount of 0.1% to 10% by weight of the composition.

4. The composition of claim 1 , wherein the composition comprises from 0.5% to 1.0% of gellan gum by weight of the composition.

5. The composition of claim 1 , wherein the composition has a viscosity of from 0.1 Pa.s to 12 Pa.s prior to application to the wound.

6. The composition of claim 1 , wherein the composition develops a viscosity of from 13 Pa.s to 800 Pa.s once in contact with the wound.

7. The composition of claim 1 in a spray device, which on actuation, the spray device discharges a metered dose of the composition.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Nov 2, 2016
From: JPMORGAN CHASE BANK, N.A.
To: CONVATEC TECHNOLOGIES, INC.; CONVATEC LIMITED; UNOMEDICAL LIMITED; UNOMEDICAL A/S
Reel/Frame 040543/0357 →
SECURITY AGREEMENT Recorded Jan 6, 2011
From: CONVATEC TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 025591/0856 →
RELEASE OF SECURITY INTEREST AT 021901/0419 Recorded Jan 4, 2011
From: J.P. MORGAN EUROPE LIMITED
To: CONVATEC TECHNOLOGIES, INC.
Reel/Frame 025580/0879 →
SECURITY AGREEMENT Recorded Dec 1, 2008
From: CONVATEC TECHNOLOGIES INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 021901/0419 →
RELEASE OF SECURITY INTEREST Recorded Nov 28, 2008
From: J.P. MORGAN EUROPE LIMITED
To: CONVATEC INC.
Reel/Frame 021890/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2008
From: BRISTOL-MYERS SQUIBB COMPANY; CONVATEC, INC.
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 021754/0611 →
SECURITY AGREEMENT Recorded Aug 12, 2008
From: CONVATEC INC.
To: J.P. MORGAN EUROPE LIMITED
Reel/Frame 021371/0796 →